Emerson’s Michalle Adkins, Benjamin Arriola & Brandon Haschke are co-authors along with professionals in leading biopharmaceutical manufacturing and suppliers in the BioPhorum work, In-line monitoring / real-time release testing in biopharmaceutical processes – prioritization and cost benefit analysis.
In a May 19 BioPharma Asia webinar, Continuous Manufacturing as a Default Platform for Oral Solid Drug Products, Emerson’s Bob Lenich will team up with Johnson and Johnson Senior Principal Engineer Lawrence De Belder to discuss the path to continuous manufacturing for these types of medicines.
Emerson’s Michalle Adkins alerted me to the release of a new BioPhorum Knowledge Management white paper, A Test Case in CMC Business Processes from Late-Stage Development to Commercial Manufacturing.
The focus of the world right now is on how to defeat the Coronavirus and return to more normal times. Manufacturers in the Life Sciences industry are racing at a breakneck pace to develop vaccines and treatments. Automation, analytics play a large role in both the...
Models of manufacturing and production processes can provide value through the lifecycle of these facilities, from up front design through ongoing personnel training and optimization. In a BioPharm International article, Biopharma modeling, now and five years from no…
As medicines and therapies become more specialized for individuals, the requirements of biopharmaceutical manufacturing processes are dramatically changing, especially in the transition from large-scale to single-use production processes. In a Processing magazine...
At the recent 2019 China International Biopharma4.0 Summit, Emerson's Ron Rossbach presented Biopharma 4.0—Integrated Software Enabling Digital Capabilities. I'll highlight some of Ron's key points. He opened describing some of the main challenges biopharmaceutical...
At this past autumn’s Emerson Exchange conference in San Antonio, Texas, Emerson’s Michalle Adkins demonstrated single use manufacturing measurement and control devices and how they could be used to measure and control biomanufacturing operations in a single use environment.
From a recent Life Sciences symposium, we looked at issues in the advancement of process intelligence and analytics. Today we'll look at another work session from the symposium, Managing Data Through the Product Life Cycle. The general session was led by Amgen's...
For pharmaceutical and biopharmaceutical manufacturers, there are a lot confusion around the concepts of design space (DS), Process Analytical Technology (PAT), and Quality by Design (QbD). Emerson's Zuwei Jin believes that this confusion has largely limited the...
The ANSI/ISA-95 standard defines models for the information flows between the instrumentation and automation layers up to the enterprise information layers for process manufacturers and producers. Moving up the levels increases the need for people, processes and...
While integration technologies have helped bridge "islands of automation" over the years, some process manufacturers still have parts of their automated processes disconnected from the rest. Emerson's Gary Mitchell, a senior industry consultant on the Life Sciences...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to keep up to date on all the latest news, events and innovations to help you take on and solve your toughest challenges.
Please do, Just link back to the post and send us a quick note so we can share your work. Thanks!
Our Global Community
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.